{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T10:42:27Z","timestamp":1789123347049,"version":"build-2803163510"},"reference-count":203,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>The insulin-like growth factor (IGF) signaling system comprises functionally specific ligands (IGF-I and IGF-II), receptor (IR), and binding proteins (IGFBP). IGFs are activated by binding to their receptor, IGF-IR, which is a tyrosine kinase receptor. This activation initiates signaling cascades such as PI3K\/Akt and MAPK\/ErK pathways, which are essential for cell proliferation, differentiation, and survival. Growing evidence links the IGF system to various hematological disorders, yet comprehensive reviews on its role in Myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) are limited. To advance understanding in this area, we aim to summarize the emerging evidence on the involvement of IGF signaling in the pathogenesis of MDS and AML. Specifically, we highlight how dysregulation of IGF-I, IGF-IR, and IGFBPs contributes to disease progression, encompassing clonal hematopoietic abnormalities, ineffective hematopoiesis in MDS, and the development of AML. The potential therapeutic implications of targeting the IGF signaling pathway, including the role of NVP-AEW541 and NVP-ADW742 effectively suppressing AML cell proliferation and enhancing chemotherapy sensitivity, are also explored. By integrating current findings, this review provides novel insights into the mechanistic role of IGF signaling in MDS and AML and its therapeutic implications, thereby guiding future research and potential clinical applications. Given the challenges, such as pathway redundancy and therapy resistance, further investigations are necessary to validate IGF-targeted therapies and optimize their clinical utility in hematologic malignancies.<\/jats:p>","DOI":"10.3389\/fonc.2025.1540426","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T05:22:29Z","timestamp":1750742549000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Advances in the role of the IGF signaling system in myelodysplastic syndromes and acute myeloid leukemia"],"prefix":"10.3389","volume":"15","author":[{"given":"Yifan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shandong","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuni","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuye","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengmei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/cells8080895","article-title":"Therapeutic targeting of the IGF axis","volume":"8","author":"Osher","year":"2019","journal-title":"Cells"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.483172","article-title":"Structural determinants of the insulin receptor-related receptor activation by alkali","volume":"288","author":"Deyev","year":"2013","journal-title":"J Biol Chem"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ghir.2019.10.004","article-title":"IGF research 2016-2018","author":"Takahashi","year":"2019","journal-title":"Growth Horm IGF Res"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0081579","article-title":"Insulin\/IGF-I signaling pathways enhances tumor cell invasion through bisecting GlcNAc N-glycans modulation. an interplay with E-cadherin","volume":"8","author":"De-Freitas-Junior","year":"2013","journal-title":"PloS One"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.2174\/1381612825666191106091507","article-title":"Effects of IGF-1 on the cardiovascular system","volume":"25","author":"Obradovic","year":"2019","journal-title":"Curr Pharm Des"},{"key":"B6","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1210\/er.2017-00073","article-title":"Insulin receptor isoforms in physiology and disease: an updated view","volume":"38","author":"Belfiore","year":"2017","journal-title":"Endocr Rev"},{"key":"B7","article-title":"Pediatric implications of normal insulin-GH-IGF axis physiology","author":"Bang","year":"2000"},{"key":"B8","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.mrrev.2016.08.007","article-title":"Insulin-like growth factor (IGF) axis in cancerogenesis","volume":"772","author":"Kasprzak","year":"2017","journal-title":"Mutat Res Rev Mutat Res"},{"key":"B9","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.molmet.2018.10.008","article-title":"The insulin like growth factor and binding protein family: Novel therapeutic targets in obesity & diabetes","volume":"19","author":"Haywood","year":"2019","journal-title":"Mol Metab"},{"key":"B10","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12943-022-01595-9","article-title":"CircVAPA promotes small cell lung cancer progression by modulating the miR-377-3p and miR-494-3p\/IGF1R\/AKT axis","volume":"21","author":"Hua","year":"2022","journal-title":"Mol Cancer"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1172\/JCI183366","article-title":"Insulin-like growth factor 2 drives fibroblast-mediated tumor immunoevasion and confers resistance to immunotherapy","volume":"134","author":"Song","year":"2024","journal-title":"J Clin Invest"},{"key":"B12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1515\/JPEM.1993.6.1.79","article-title":"The effect of growth hormone and IGF-I on clonogenic growth of hematopoietic cells in leukemic patients during active disease and during remission\u2013a preliminary report","volume":"6","author":"Zadik","year":"1993","journal-title":"J Pediatr Endocrinol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1999.tb01743.x","article-title":"In vitro effects of insulin-like growth factor-1 (IGF-1) on proliferation and constitutive cytokine secretion by acute myelogenous leukemia blasts","volume":"62","author":"Frostad","year":"1999","journal-title":"Eur J Haematol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.7534\/j.issn.1009-2137.2018.03.036","article-title":"Expression of insulin-like growth factor recepter type I in CD34(+) cells of patients with myelodysplastic syndromes","volume":"26","author":"Zhang","year":"2018","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2014.2569","article-title":"A subset of bone marrow stromal cells regulate ATP-binding cassette gene expression via insulin-like growth factor-I in a leukemia cell line","volume":"45","author":"Benabbou","year":"2014","journal-title":"Int J Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023020078","article-title":"Diagnosis and classification of myelodysplastic syndromes","volume":"142","author":"Hasserjian","year":"2023","journal-title":"Blood"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26822","article-title":"Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management","volume":"98","author":"Shimony","year":"2023","journal-title":"Am J Hematol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1182\/blood.2019000942","article-title":"Genetics of progression from MDS to secondary leukemia","volume":"136","author":"Menssen","year":"2020","journal-title":"Blood"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.60.0890","article-title":"Epidemiology and clinical significance of secondary and therapy-related acute myeloid leukemia: A national population-based cohort study","volume":"33","author":"Granfeldt","year":"2015","journal-title":"J Clin Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23908","article-title":"Characterization and prognostic features of secondary acute myeloid leukemia in a population-based setting: a report from the Swedish Acute Leukemia Registry","volume":"90","author":"Huleg\u00e5rdh","year":"2015","journal-title":"Am J Hematol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24065734","article-title":"The genetic landscape of myelodysplastic neoplasm progression to acute myeloid leukemia","volume":"24","author":"B\u0103nescu","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0267-4","article-title":"Myelodysplastic syndrome progression to acute myeloid leukemia at the stem cell level","volume":"25","author":"Chen","year":"2019","journal-title":"Nat Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41408-021-00547-8","article-title":"Therapeutic targeting of the inflammasome in myeloid Malignancies","volume":"11","author":"Chakraborty","year":"2021","journal-title":"Blood Cancer J"},{"key":"B24","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s12308-011-0088-6","article-title":"The AML\u2013MDS interface\u2014leukemic transformation in myelodysplastic syndromes","volume":"4","author":"Porwit","year":"2011","journal-title":"J Hematop"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404643","article-title":"The insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 induces apoptosis in acute myeloid leukemia cells exhibiting autocrine insulin-like growth factor-I secretion","volume":"21","author":"Tazzari","year":"2007","journal-title":"Leukemia"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2017.197","article-title":"The bone-marrow niche in MDS and MGUS: implications for AML and MM","volume":"15","author":"Ghobrial","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/j.ccell.2022.10.004","article-title":"The m(6)A reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia","volume":"40","author":"Weng","year":"2022","journal-title":"Cancer Cell"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-22-0414","article-title":"GH and IGF1 in cancer therapy resistance","volume":"30","author":"Basu","year":"2023","journal-title":"Endocr Relat Cancer"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.4248\/BR201303003","article-title":"Autocrine and paracrine actions of IGF-I signaling in skeletal development","volume":"1","author":"Wang","year":"2013","journal-title":"Bone Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.010785","article-title":"Autocrine IGF-1\/IGF-1R signaling is responsible for constitutive PI3K\/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R antibody","volume":"95","author":"Chapuis","year":"2010","journal-title":"Haematologica"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/cells9091970","article-title":"Mechanisms of IGF-1-mediated regulation of skeletal muscle hypertrophy and atrophy","volume":"9","author":"Yoshida","year":"2020","journal-title":"Cells"},{"key":"B32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/sj.cr.7290105","article-title":"MAPK signal pathways in the regulation of cell proliferation in mammalian cells","volume":"12","author":"Zhang","year":"2002","journal-title":"Cell Res"},{"key":"B33","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1080\/01902148.2017.1282994","article-title":"Inhibiting IGF-1R attenuates cell proliferation and VEGF production in IGF-1R over-expressing EGFR mutant non-small cell lung cancer cells","volume":"43","author":"Yeo","year":"2017","journal-title":"Exp Lung Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002722","article-title":"IGF1 receptor inhibition amplifies the effects of cancer drugs by autophagy and immune-dependent mechanisms","volume":"9","author":"Wu","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-022-00649-8","article-title":"Skeletal disorders associated with the growth hormone-insulin-like growth factor 1 axis","volume":"18","author":"Mazziotti","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s10695-018-0570-5","article-title":"Molecular characterization and expression profiles of insulin-like growth factors in yellowtail kingfish (Seriola lalandi) during embryonic development","volume":"45","author":"Wang","year":"2019","journal-title":"Fish Physiol Biochem"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s11523-017-0514-5","article-title":"Insulin-like growth factor (IGF) pathway targeting in cancer: role of the IGF axis and opportunities for future combination studies","volume":"12","author":"Simpson","year":"2017","journal-title":"Target Oncol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s12013-021-00989-8","article-title":"IGF-1R transported to the cell nuclei to regulate the proliferation of breast cancer cells","volume":"79","author":"Guo","year":"2021","journal-title":"Cell Biochem Biophys"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.v136.10","article-title":"Prediagnostic plasma IGFBP-1, IGF-1 and risk of prostate cancer","volume":"136","author":"Cao","year":"2015","journal-title":"Int J Cancer"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2016.00052","article-title":"IGF-I: A key growth factor that regulates neurogenesis and synaptogenesis from embryonic to adult stages of the brain","volume":"10","author":"Nieto-Est\u00e9vez","year":"2016","journal-title":"Front Neurosci"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1987810","article-title":"Delta40p53 controls the switch from pluripotency to differentiation by regulating IGF signaling in ESCs","volume":"24","author":"Ungewitter","year":"2010","journal-title":"Genes Dev"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S51997","article-title":"Expression and clinical significance of IGF-1, IGFBP-3, and IGFBP-7 in serum and lung cancer tissues from patients with non-small cell lung cancer","volume":"6","author":"Wang","year":"2013","journal-title":"Onco Targets Ther"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1480177","article-title":"Augmented serum levels of the IGF-I\/IGF-binding protein-3 ratio in pre-menopausal patients with type I breast cysts","volume":"148","author":"Enriori","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S1055-3207(18)30066-8","article-title":"The receptor for the type I insulin-like growth factor and its ligands regulate multiple cellular functions that impact on metastasis","volume":"10","author":"Samani","year":"2001","journal-title":"Surg Oncol Clin N Am"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/j.cmet.2023.06.007","article-title":"Fetal manipulation of maternal metabolism is a critical function of the imprinted Igf2 gene","volume":"35","author":"Lopez-Tello","year":"2023","journal-title":"Cell Metab"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20194915","article-title":"Insulin-like growth factor 2 (IGF2) signaling in colorectal cancer-from basic research to potential clinical applications","volume":"20","author":"Kasprzak","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.3c08886","article-title":"Insulin-like growth factor 2 (IGF2)-fused lysosomal targeting chimeras for degradation of extracellular and membrane proteins","volume":"145","author":"Zhang","year":"2023","journal-title":"J Am Chem Soc"},{"key":"B48","doi-asserted-by":"publisher","first-page":"S2090-1232(24)00564-2","DOI":"10.1016\/j.jare.2024.12.008","article-title":"CD34(+)CLDN5(+) tumor associated senescent endothelial cells through IGF2-IGF2R signaling increased cholangiocellular phenotype in hepatocellular carcinoma","volume":"12","author":"Zhu","year":"2024","journal-title":"J Adv Res"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1126\/science.1092952","article-title":"Insulin signaling in health and disease","volume":"302","author":"White","year":"2003","journal-title":"Science"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.ghir.2017.11.007","article-title":"The IGF-p53 connection in cancer","volume":"39","author":"Conover","year":"2018","journal-title":"Growth Horm IGF Res"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.7555\/JBR.34.20200082","article-title":"Insulin receptor is implicated in triple-negative breast cancer by decreasing cell mobility","volume":"35","author":"Yang","year":"2020","journal-title":"J BioMed Res"},{"key":"B52","doi-asserted-by":"publisher","first-page":"393","DOI":"10.18632\/oncotarget.28202","article-title":"The role of IGF-pathway biomarkers in determining risks, screening, and prognosis in lung cancer","volume":"13","author":"Pohlman","year":"2022","journal-title":"Oncotarget"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2022.2048432","article-title":"TET2 regulates osteoclastogenesis by modulating autophagy in OVX-induced bone loss","volume":"18","author":"Yang","year":"2022","journal-title":"Autophagy"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12051228","article-title":"Role of tumor and stroma-derived IGF\/IGFBPs in pancreatic cancer","volume":"12","author":"Thomas","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3720","article-title":"IGF binding proteins in cancer: mechanistic and clinical insights","volume":"14","author":"Baxter","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"B56","first-page":"5997","article-title":"The protooncogene c-myb increases the expression of insulin-like growth factor 1 and insulin-like growth factor 1 receptor messenger RNAs by a transcriptional mechanism","volume":"51","author":"Reiss","year":"1991","journal-title":"Cancer Res"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2014.00472","article-title":"Regulation of IGF -1 signaling by microRNAs","volume":"5","author":"Jung","year":"2014","journal-title":"Front Genet"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-0511","article-title":"Expression of insulin receptor isoform A and insulin-like growth factor-1 receptor in human acute myelogenous leukemia: effect of the dual-receptor inhibitor BMS-536924 in vitro","volume":"69","author":"Wahner","year":"2009","journal-title":"Cancer Res"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.625943","article-title":"Niche modulation of IGF-1R signaling: its role in stem cell pluripotency, cancer reprogramming, and therapeutic applications","volume":"8","author":"Chen","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.1038\/ncomms4472","article-title":"Cancer-associated fibroblasts regulate the plasticity of lung cancer stemness via paracrine signalling","volume":"5","author":"Chen","year":"2014","journal-title":"Nat Commun"},{"key":"B61","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1038\/s41467-025-57551-w","article-title":"Placenta-derived factors contribute to human iPSC-liver organoid growth","volume":"16","author":"Kuse","year":"2025","journal-title":"Nat Commun"},{"key":"B62","article-title":"The character of heredity and biological function of insulin-like growth factor 2","volume":"24","author":"Liu","year":"2002","journal-title":"Yi Chuan"},{"key":"B63","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12943-024-02204-7","article-title":"Mir-483-5p-mediated activating of IGF2\/H19 enhancer up-regulates IGF2\/H19 expression via chromatin loops to promote the Malignant progression of hepatocellular carcinoma","volume":"24","author":"Chen","year":"2025","journal-title":"Mol Cancer"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3892\/or.2013.2646","article-title":"Gene therapy for cancer through adenovirus vector\u2212mediated expression of the Ad5 early region gene 1A based on loss of IGF2 imprinting","volume":"30","author":"Pan","year":"2013","journal-title":"Oncol Rep"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3390\/cells11121886","article-title":"IGF2: development, genetic and epigenetic abnormalities","volume":"11","author":"S\u00e9l\u00e9nou","year":"2022","journal-title":"Cells"},{"key":"B66","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.tins.2023.03.007","article-title":"IGF2 in memory, neurodevelopmental disorders, and neurodegenerative diseases","volume":"46","author":"Alberini","year":"2023","journal-title":"Trends Neurosci"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.1994.266.2.C319","article-title":"The insulin receptor: structure, function, and signaling","volume":"266","author":"Lee","year":"1994","journal-title":"Am J Physiol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-9822(02)00777-7","article-title":"The insulin signalling pathway","volume":"12","author":"Lizcano","year":"2002","journal-title":"Curr Biol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14715\/cmb\/2017.63.1.1","article-title":"The role of insulin receptor substrate (IRS) proteins in oncogenic transformation","volume":"63","author":"Gorgisen","year":"2017","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1111\/cns.2018.24.issue-9","article-title":"Insulin receptor in the brain: Mechanisms of activation and the role in the CNS pathology and treatment","volume":"24","author":"Pomytkin","year":"2018","journal-title":"CNS Neurosci Ther"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2017.01.017","article-title":"IGFBP, a novel target of lung cancer","volume":"466","author":"Hu","year":"2017","journal-title":"Clin Chim Acta"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00499","article-title":"Insulin-like growth factor binding proteins in autoimmune diseases","volume":"9","author":"Ding","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-07-0148","article-title":"Genetic disorders in the GH IGF-I axis in mouse and man","author":"Walenkamp","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.jchf.2022.09.004","article-title":"IGFBP-7 and outcomes in heart failure with reduced ejection fraction: findings from DAPA-HF","volume":"11","author":"Adamson","year":"2023","journal-title":"JACC heart fail"},{"key":"B75","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/978-3-642-04302-4_3","article-title":"IGFBP2 Supports ex vivo Expansion of Hematopoietic Stem Cells","volume":"2010","author":"Huynh","year":"2010","journal-title":"IGFs: Local Repair Survival Fact Throughout Life Span"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1053\/beem.2002.0212","article-title":"IGFs and IGFBPs: role in health and disease","volume":"16","author":"Monzavi","year":"2002","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1210\/en.2011-0047","article-title":"Evolution of the insulin-like growth factor binding protein (IGFBP) family","volume":"152","author":"Daza","year":"2011","journal-title":"Endocrinology"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0022456","article-title":"Skp2B overexpression alters a prohibitin-p53 axis and the transcription of PAPP-A, the protease of insulin-like growth factor binding protein 4","volume":"6","author":"Chander","year":"2011","journal-title":"PloS One"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2012.02.008","article-title":"Key questions and answers about pregnancy-associated plasma protein-A","volume":"23","author":"Conover","year":"2012","journal-title":"Trends Endocrinol Metab"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1210\/me.2006-0522","article-title":"Regulation of insulin-like growth factor (IGF) bioactivity by sequential proteolytic cleavage of IGF binding protein-4 and -5","volume":"21","author":"Laursen","year":"2007","journal-title":"Mol Endocrinol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202406965","article-title":"Delayed administration of IGFBP7 improved bone defect healing via ZO-1 dependent vessel stabilization","volume":"12","author":"Sun","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.83.7.5097","article-title":"Identification of glycosylated 38-kDa connective tissue growth factor (IGFBP-related protein 2) and proteolytic fragments in human biological fluids, and up-regulation of IGFBP-rP2 expression by TGF-beta in Hs578T human breast cancer cells","volume":"83","author":"Yang","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"B83","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/pcan.2012.41","article-title":"A functional polymorphism in the CYR61 (IGFBP10) gene is associated with prostate cancer risk","volume":"16","author":"Tao","year":"2013","journal-title":"Prost Cancer Prost Dis"},{"key":"B84","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41420-023-01336-x","article-title":"Cancer-associated fibroblast-secreted IGFBP7 promotes gastric cancer by enhancing tumor associated macrophage infiltration via FGF2\/FGFR1\/PI3K\/AKT axis","volume":"9","author":"Li","year":"2023","journal-title":"Cell Death Discov"},{"key":"B85","doi-asserted-by":"publisher","first-page":"104787","DOI":"10.1016\/j.yexmp.2022.104787","article-title":"The PI3K\/AKT signaling pathway in cancer: Molecular mechanisms and possible therapeutic interventions","volume":"127","author":"Khezri","year":"2022","journal-title":"Exp Mol Pathol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","article-title":"Targeting PI3K\/Akt signal transduction for cancer therapy","volume":"6","author":"He","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B87","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jbior.2017.06.003","article-title":"GSK3 and its interactions with the PI3K\/AKT\/mTOR signalling network","volume":"65","author":"Hermida","year":"2017","journal-title":"Adv Biol Regul"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-13-1729","article-title":"FoxO transcription factors promote AKT Ser473 phosphorylation and renal tumor growth in response to pharmacologic inhibition of the PI3K-AKT pathway","volume":"74","author":"Lin","year":"2014","journal-title":"Cancer Res"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-024-01592-8","article-title":"MDM2 functions as a timer reporting the length of mitosis","volume":"27","author":"Fulcher","year":"2025","journal-title":"Nat Cell Biol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-05940-w","article-title":"PI3K\u03b2 controls immune evasion in PTEN-deficient breast tumours","volume":"617","author":"Bergholz","year":"2023","journal-title":"Nature"},{"key":"B91","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.ccell.2021.02.006","article-title":"MDMX acts as a pervasive preleukemic-to-acute myeloid leukemia transition mechanism","volume":"39","author":"Ueda","year":"2021","journal-title":"Cancer Cell"},{"key":"B92","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","author":"Glaviano","year":"2023","journal-title":"Mol Cancer"},{"key":"B93","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12943-024-02072-1","article-title":"Targeting PI3K family with small-molecule inhibitors in cancer therapy: current clinical status and future directions","volume":"23","author":"Li","year":"2024","journal-title":"Mol Cancer"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1080\/01635581.2019.1578387","article-title":"Involvement of the PI3K\/akt\/nrf2 signaling pathway in resveratrol-mediated reversal of drug resistance in HL-60\/ADR cells","volume":"71","author":"Li","year":"2019","journal-title":"Nutr Cancer"},{"key":"B95","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12906-021-03328-9","article-title":"The polyphenol\/saponin-rich Rhus tripartita extract has an apoptotic effect on THP-1 cells through the PI3K\/AKT\/mTOR signaling pathway","volume":"21","author":"Tlili","year":"2021","journal-title":"BMC Complement Med Ther"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404057","article-title":"Frequent elevation of Akt kinase phosphorylation in blood marrow and peripheral blood mononuclear cells from high-risk myelodysplastic syndrome patients","volume":"20","author":"Ny\u00e5kern","year":"2006","journal-title":"Leukemia"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.cell.2017.07.032","article-title":"Restoration of TET2 function blocks aberrant self-renewal and leukemia progression","volume":"170","author":"Cimmino","year":"2017","journal-title":"Cell"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2011.09.013","article-title":"Clinical implications of novel mutations in epigenetic modifiers in AML","volume":"25","author":"Abdel-Wahab","year":"2011","journal-title":"Hematol Oncol Clin North Am"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1038\/nature25434","article-title":"Tet2 promotes pathogen infection-induced myelopoiesis through mRNA oxidation","volume":"554","author":"Shen","year":"2018","journal-title":"Nature"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-015-1867-5","article-title":"Targeting PI3K\/AKT\/mTOR network for treatment of leukemia","volume":"72","author":"Bertacchini","year":"2015","journal-title":"Cell Mol Life Sci"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2016.01.012","article-title":"PI3K\/Akt\/mTOR and Ras\/Raf\/MEK\/ERK signaling pathways inhibitors as anticancer agents: Structural and pharmacological perspectives","volume":"109","author":"Asati","year":"2016","journal-title":"Eur J Med Chem"},{"key":"B102","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41392-023-01705-z","article-title":"Targeting the RAS\/RAF\/MAPK pathway for cancer therapy: from mechanism to clinical studies","volume":"8","author":"Bahar","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2016.10.029","article-title":"Inhibition of ras\/raf\/MEK\/ERK pathway signaling by a stress-induced phospho-regulatory circuit","volume":"64","author":"Ritt","year":"2016","journal-title":"Mol Cell"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0209097","article-title":"MAPK signaling pathways in the regulation of hematopoiesis","volume":"86","author":"Geest","year":"2009","journal-title":"J Leukoc Biol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"115842","DOI":"10.1016\/j.bcp.2023.115842","article-title":"Unraveling the interplay between RAS\/RAF\/MEK\/ERK signaling pathway and autophagy in cancer: From molecular mechanisms to targeted therapy","volume":"217","author":"Huang","year":"2023","journal-title":"Biochem Pharmacol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27271","article-title":"Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification and management","volume":"99","author":"Patnaik","year":"2024","journal-title":"Am J Hematol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01718-7","article-title":"Comparison of the revised 4th (2016) and 5th (2022) editions of the World Health Organization classification of myelodysplastic neoplasms","volume":"36","author":"Zhang","year":"2022","journal-title":"Leukemia"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1038\/nrd4281","article-title":"Targeting RAS-ERK signalling in cancer: promises and challenges","volume":"13","author":"Samatar","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"B109","doi-asserted-by":"publisher","first-page":"101214","DOI":"10.1016\/j.drup.2025.101214","article-title":"Centromere protein U mediates the ubiquitination and degradation of RPS3 to facilitate temozolomide resistance in glioblastoma","volume":"80","author":"Sun","year":"2025","journal-title":"Drug Resist Updat"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-022-00718-5","article-title":"Non-canonical WNT signalling in cardiovascular disease: mechanisms and therapeutic implications","volume":"19","author":"Akoumianakis","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41392-021-00701-5","article-title":"Wnt\/\u03b2-catenin signaling in cancers and targeted therapies","volume":"6","author":"Yu","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B112","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1095\/biolreprod.112.102608","article-title":"FZD1 regulates cumulus expansion genes and is required for normal female fertility in mice","volume":"87","author":"Lapointe","year":"2012","journal-title":"Biol Reprod"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0195126","article-title":"A Boolean network of the crosstalk between IGF and Wnt signaling in aging satellite cells","volume":"13","author":"Siegle","year":"2018","journal-title":"PloS One"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.210394297","article-title":"Insulin-like growth factor 1 regulates the location, stability, and transcriptional activity of beta-catenin","volume":"97","author":"Playford","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202100914","article-title":"Cytoplasmic NEAT1 suppresses AML stem cell self-renewal and leukemogenesis through inactivation of wnt signaling","volume":"8","author":"Yan","year":"2021","journal-title":"Adv Sci (Weinh)"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1038\/s44321-024-00024-2","article-title":"Targeting the mevalonate or Wnt pathways to overcome CAR T-cell resistance in TP53-mutant AML cells","volume":"16","author":"Mueller","year":"2024","journal-title":"EMBO Mol Med"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.3390\/cells14040269","article-title":"Hedgehog and PI3K\/akt\/mTOR signaling pathways involvement in leukemic Malignancies: crosstalk and role in cell death","volume":"14","author":"Sicurella","year":"2025","journal-title":"Cells"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-019-0293-2","article-title":"Targeting signalling pathways and the immune microenvironment of cancer stem cells - a clinical update","volume":"17","author":"Clara","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adq1790","article-title":"Morphogen-induced kinase condensates transduce Hh signal by allosterically activating Gli","volume":"11","author":"Han","year":"2025","journal-title":"Sci Adv"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2010.375","article-title":"Hedgehog signaling maintains chemoresistance in myeloid leukemic cells","volume":"29","author":"Queiroz","year":"2010","journal-title":"Oncogene"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.3390\/biology10040255","article-title":"Understanding the hedgehog signaling pathway in acute myeloid leukemia stem cells: A necessary step toward a cure","volume":"10","author":"Lainez-Gonz\u00e1lez","year":"2021","journal-title":"Biol (Basel)"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2022111513","article-title":"GRAMD1\/ASTER-mediated cholesterol transport promotes Smoothened cholesterylation at the endoplasmic reticulum","volume":"42","author":"Qiu","year":"2023","journal-title":"EMBO J"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202152537","article-title":"p53 transcriptionally regulates SQLE to repress cholesterol synthesis and tumor growth","volume":"22","author":"Sun","year":"2021","journal-title":"EMBO Rep"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1159\/000443075","article-title":"Targeting GLI1 suppresses cell growth and enhances chemosensitivity in CD34+ Enriched acute myeloid leukemia progenitor cells","volume":"38","author":"Long","year":"2016","journal-title":"Cell Physiol Biochem"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1038\/nature07737","article-title":"Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia","volume":"458","author":"Zhao","year":"2009","journal-title":"Nature"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-1777","article-title":"Combination of ponatinib with Hedgehog antagonist vismodegib for therapy-resistant BCR-ABL1-positive leukemia","volume":"19","author":"Katagiri","year":"2013","journal-title":"Clin Cancer Res"},{"key":"B127","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1478-811X-12-11","article-title":"Hepatic Hedgehog signaling contributes to the regulation of IGF1 and IGFBP1 serum levels","volume":"12","author":"Matz-Soja","year":"2014","journal-title":"Cell Commun Signal"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1080\/14737140.2019.1652095","article-title":"Hedgehog pathway inhibition as a therapeutic target in acute myeloid leukemia","volume":"19","author":"Shallis","year":"2019","journal-title":"Expert Rev Anticancer Ther"},{"key":"B129","doi-asserted-by":"publisher","first-page":"196","DOI":"10.6004\/jadpro.2020.11.2.8","article-title":"Glasdegib: A novel hedgehog pathway inhibitor for acute myeloid leukemia","volume":"11","author":"Thompson","year":"2020","journal-title":"J Adv Pract Oncol"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V124.21.3612.3612","article-title":"Hh\/IGF-1R\/PI3K\/Akt\/MRP1 pathway induce refractory acute myeloid leukemia and its targeting therpy","author":"Huang","year":"2014","journal-title":"Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster III"},{"key":"B131","doi-asserted-by":"publisher","first-page":"117503","DOI":"10.1016\/j.lfs.2020.117503","article-title":"IGF-1 promotes multiple myeloma progression through PI3K\/Akt-mediated epithelial-mesenchymal transition","volume":"249","author":"Peng","year":"2020","journal-title":"Life Sci"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-06-2066","article-title":"Insulin-like growth factor I induces migration and invasion of human multiple myeloma cells","volume":"103","author":"Qiang","year":"2004","journal-title":"Blood"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2013.03.002","article-title":"HGF and IGF-1 synergize with SDF-1\u03b1 in promoting migration of myeloma cells by cooperative activation of p21-activated kinase","volume":"41","author":"R\u00f8","year":"2013","journal-title":"Exp Hematol"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.61186\/ijbc.16.3.32","article-title":"IGF gene family expression: A comparative study in acute myeloid leukemia (AML) and healthy bone marrow","volume":"16","author":"Moonesi","year":"2024","journal-title":"Iran J Blood Cancer"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-2989442\/v1","article-title":"Comparison of the relative expression of the IGF gene family in the bone marrow of patients with AML compared with normal individuals","author":"Moonesi","year":"2023"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.3390\/biom13121701","article-title":"Engagement of mesenchymal stromal cells in the remodeling of the bone marrow microenvironment in hematological cancers","volume":"13","author":"Giallongo","year":"2023","journal-title":"Biomolecules"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1080\/10245332.2018.1486064","article-title":"Roles of the bone marrow niche in hematopoiesis, leukemogenesis, and chemotherapy resistance in acute myeloid leukemia","volume":"23","author":"Wang","year":"2018","journal-title":"Hematology"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1179\/1607845413Y.0000000111","article-title":"Bone marrow neoplastic niche in leukemia","volume":"19","author":"Azizidoost","year":"2014","journal-title":"Hematology"},{"key":"B139","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13287-025-04154-3","article-title":"MSCs with upregulated lipid metabolism block hematopoietic stem cell differentiation via exosomal CTP-1A in MDS","volume":"16","author":"Yin","year":"2025","journal-title":"Stem Cell Res Ther"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2017.6741","article-title":"Mesenchymal stem cells promote endothelial progenitor cell proliferation by secreting insulin\u2212like growth factor\u22121","volume":"16","author":"Hou","year":"2017","journal-title":"Mol Med Rep"},{"key":"B141","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.3390\/molecules21111512","article-title":"The complexity of targeting PI3K-akt-mTOR signalling in human acute myeloid leukaemia: the importance of leukemic cell heterogeneity, neighbouring mesenchymal stem cells and immunocompetent cells","volume":"21","author":"Brenner","year":"2016","journal-title":"Molecules"},{"key":"B142","doi-asserted-by":"publisher","first-page":"9453108","DOI":"10.1155\/2017\/9453108","article-title":"The roles of insulin-like growth factors in mesenchymal stem cell niche","volume":"2017","author":"Youssef","year":"2017","journal-title":"Stem Cells Int"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2015.13","article-title":"Paracrine factors of human fetal MSCs inhibit liver cancer growth through reduced activation of IGF-1R\/PI3K\/Akt signaling","volume":"23","author":"Yulyana","year":"2015","journal-title":"Mol Ther"},{"key":"B144","doi-asserted-by":"publisher","first-page":"604","DOI":"10.3892\/mmr.2021.12249","article-title":"M2\u2212like tumour\u2212associated macrophage\u2212secreted IGF promotes thyroid cancer stemness and metastasis by activating the PI3K\/AKT\/mTOR pathway","volume":"24","author":"Lv","year":"2021","journal-title":"Mol Med Rep"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.v236.6","article-title":"IGF family effects on development, stability, and treatment of hematological Malignancies","volume":"236","author":"Moonesi","year":"2021","journal-title":"J Cell Physiol"},{"key":"B146","article-title":"The relationship of blood glucose and the expression of insulin-like growth factor-1 receptor mRNA in diabetic cardiomyopathy: a preliminary study with rats","volume":"87","author":"Kuang","year":"2007","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.3892\/or.2011.1233","article-title":"The insulin-like growth factor-I receptor kinase inhibitor NVP-ADW742 sensitizes medulloblastoma to the effects of chemotherapy","volume":"25","author":"Zhou","year":"2011","journal-title":"Oncol Rep"},{"key":"B148","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1159\/000345427","article-title":"Metabolism-related cytokine and hormone levels in the serum of patients with myelodysplastic syndromes","volume":"130","author":"Bouronikou","year":"2013","journal-title":"Acta Haematol"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15215297","article-title":"PI3K\/akt\/mTOR signaling pathway in blood Malignancies-new therapeutic possibilities","volume":"15","author":"Wiese","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9092934","article-title":"Targeting PI3K\/akt\/mTOR in AML: rationale and clinical evidence","volume":"9","author":"Darici","year":"2020","journal-title":"J Clin Med"},{"key":"B151","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.canlet.2018.10.028","article-title":"ADAM28 promotes tumor growth and dissemination of acute myeloid leukemia through IGFBP-3 degradation and IGF-I-induced cell proliferation","volume":"442","author":"Zhang","year":"2019","journal-title":"Cancer Lett"},{"key":"B152","doi-asserted-by":"publisher","first-page":"10","DOI":"10.21037\/sci-2022-044","article-title":"Leukemic stem cells and advances in hematopoietic stem cell transplantation for acute myeloid leukemia: a narrative review of clinical trials","volume":"9","author":"Sumbly","year":"2022","journal-title":"Stem Cell Investig"},{"key":"B153","article-title":"Evaluation of selected endocrine complications in patients treated with auto- and allo-haematopoietic stem cell transplantation","volume":"12","author":"Niedzielska","year":"2008","journal-title":"Med Wieku Rozwoj"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-024-03561-x","article-title":"The role of IGF\/IGF-1R signaling in the regulation of cancer stem cells","volume":"26","author":"Liu","year":"2024","journal-title":"Clin Transl Oncol"},{"key":"B155","article-title":"The type I insulin-like growth factor receptor highly expressed in clonal cells of myelodysplastic syndromes","volume":"32","author":"He","year":"2011","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.3109\/07357907.2010.489537","article-title":"Overexpression of IGF-IR in Malignant clonal cells in bone marrow of myelodysplastic syndromes","volume":"28","author":"He","year":"2010","journal-title":"Cancer Invest"},{"key":"B157","article-title":"Expression of insulin-like growth factor receptor type I in marrow nucleated cells from hematologic Malignancies and its anti-apoptotic effect","volume":"13","author":"He","year":"2005","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0140372","article-title":"Purification of bone marrow clonal cells from patients with myelodysplastic syndrome via IGF-IR","volume":"10","author":"He","year":"2015","journal-title":"PloS One"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.3892\/or.2020.7652","article-title":"IGF\u2212IR promotes clonal cell proliferation in myelodysplastic syndromes via inhibition of the MAPK pathway","volume":"44","author":"He","year":"2020","journal-title":"Oncol Rep"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.14288\/1.0415838","article-title":"Overcoming lenalidomide resistance in del (5q) myelodysplastic syndrome","author":"Gharaee","year":"2022","journal-title":"The University of British Columbia"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-025-02537-2","article-title":"Haploinsufficiency of miR-143 and miR-145 reveal targetable dependencies in resistant del(5q) myelodysplastic neoplasm","volume":"39","author":"Gharaee","year":"2025","journal-title":"Leukemia"},{"key":"B162","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00277-005-0031-y","article-title":"Expression of type 1 insulin-like growth factor receptor in marrow nucleated cells in Malignant hematological disorders: correlation with apoptosis","volume":"85","author":"Qi","year":"2006","journal-title":"Ann Hematol"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S192137","article-title":"RETRACTED ARTICLE: microRNA-628 inhibits the proliferation of acute myeloid leukemia cells by directly targeting IGF-1R","author":"Chen","year":"2019","journal-title":"Onco Targets Ther"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-0902","article-title":"Upregulation of IGF1R by mutant RAS in leukemia and potentiation of RAS signaling inhibitors by small-molecule inhibition of IGF1R","volume":"20","author":"Weisberg","year":"2014","journal-title":"Clin Cancer Res"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.57","article-title":"HoxA9 induces insulin-like growth factor-1 receptor expression in B-lineage acute lymphoblastic leukemia","volume":"22","author":"Whelan","year":"2008","journal-title":"Leukemia"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-023-05378-0","article-title":"Insulin-like growth factor 1 receptor inhibits the proliferation of acute myeloid leukaemia cells via NK cell activation","volume":"102","author":"Wang","year":"2023","journal-title":"Ann Hematol"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21082907","article-title":"The PI3K-akt-mTOR signaling pathway in human acute myeloid leukemia (AML) cells","volume":"21","author":"Nepstad","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2007.05.005","article-title":"Targeting receptor tyrosine kinase signaling in acute myeloid leukemia","volume":"63","author":"Doepfner","year":"2007","journal-title":"Crit Rev Oncol Hematol"},{"key":"B169","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.canlet.2014.11.052","article-title":"SUMOylation of insulin-like growth factor 1 receptor, promotes proliferation in acute myeloid leukemia","volume":"357","author":"Zhang","year":"2015","journal-title":"Cancer Lett"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-03-080796","article-title":"Mammalian target of rapamycin (mTOR) inhibition activates phosphatidylinositol 3-kinase\/Akt by up-regulating insulin-like growth factor-1 receptor signaling in acute myeloid leukemia: rationale for therapeutic inhibition of both pathways","volume":"111","author":"Tamburini","year":"2008","journal-title":"Blood"},{"key":"B171","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3892\/ijo.26.2.499","article-title":"Down-regulation of the IGF-2\/H19 locus during normal and Malignant hematopoiesis is independent of the imprinting pattern","volume":"26","author":"Tessema","year":"2005","journal-title":"Int J Oncol"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00687","article-title":"The IGF2\/IGF1R\/Nanog signaling pathway regulates the proliferation of acute myeloid leukemia stem cells","volume":"9","author":"Xu","year":"2018","journal-title":"Front Pharmacol"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403672","article-title":"High IGFBP-3 levels in marrow plasma in early-stage MDS: effects on apoptosis and hemopoiesis","volume":"19","author":"Wilson","year":"2005","journal-title":"Leukemia"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.04.015","article-title":"Adiponectin and resistin are associated with risk for myelodysplastic syndrome, independently from the insulin-like growth factor-I (IGF-I) system","volume":"44","author":"Dalamaga","year":"2008","journal-title":"Eur J Cancer"},{"key":"B175","article-title":"Expression of insulin-like growth factor\u2013binding protein-2 and 7 (IGFBP2 and IGFBP7) genes in acute myeloid leukemia","volume":"14","author":"Nabawy","year":"2018","journal-title":"Journal of the Egyptian Society of Haematology & Research"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2011.08.006","article-title":"High expression of IGFBP2 is associated with chemoresistance in adult acute myeloid leukemia","volume":"35","author":"K\u00fchnl","year":"2011","journal-title":"Leuk Res"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21294","article-title":"Expression of components of the IGF axis in childhood acute myelogenous leukemia","volume":"50","author":"Dawczynski","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705281","article-title":"Elevated serum insulin-like growth factor binding protein-2 is associated with a high relapse risk after hematopoietic stem cell transplantation in childhood AML","volume":"37","author":"Dawczynski","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"B179","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/1756-8722-6-72","article-title":"IGF binding protein 2 is a cell-autonomous factor supporting survival and migration of acute leukemia cells","volume":"6","author":"Chen","year":"2013","journal-title":"J Hematol Oncol"},{"key":"B180","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.ccell.2018.08.016","article-title":"Subversion of systemic glucose metabolism as a mechanism to support the growth of leukemia cells","volume":"34","author":"Ye","year":"2018","journal-title":"Cancer Cell"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2015.1022767","article-title":"Impact of insulin-like growth factor 1 and insulin-like growth factor binding proteins on outcomes in acute myeloid leukemia","volume":"56","author":"Karmali","year":"2015","journal-title":"Leuk Lymph"},{"key":"B182","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1016\/j.celrep.2018.11.062","article-title":"IGFBP7 induces differentiation and loss of survival of human acute myeloid leukemia stem cells without affecting normal hematopoiesis","volume":"25","author":"Verhagen","year":"2018","journal-title":"Cell Rep"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.268","article-title":"IGFBP7 induces apoptosis of acute myeloid leukemia cells and synergizes with chemotherapy in suppression of leukemia cell survival","volume":"5","author":"Verhagen","year":"2014","journal-title":"Cell Death Dis"},{"key":"B184","doi-asserted-by":"publisher","first-page":"5134","DOI":"10.1182\/blood-2018-99-119528","article-title":"IGFBP7 as a potential therapeutic target for AML","volume":"132","author":"Niu","year":"2018","journal-title":"Blood"},{"key":"B185","doi-asserted-by":"publisher","first-page":"100952","DOI":"10.1016\/j.neo.2023.100952","article-title":"Secreted insulin-like growth factor binding protein 5 functions as a tumor suppressor and chemosensitizer through inhibiting insulin-like growth factor 1 receptor\/protein kinase B pathway in acute myeloid leukemia","volume":"47","author":"Zhang","year":"2024","journal-title":"Neoplasia"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.685954","article-title":"Network pharmacology and experimental validation reveal the effects of chidamide combined with aspirin on acute myeloid leukemia-myelodysplastic syndrome cells through PI3K\/AKT pathway","volume":"9","author":"Liang","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.14378","article-title":"Phase 1b study of IGF-methotrexate conjugate in the treatment of high-grade myelodysplastic syndromes","volume":"40","author":"Alkhateeb","year":"2020","journal-title":"Anticancer Res"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046853","article-title":"Matrine induces apoptosis in human acute myeloid leukemia cells via the mitochondrial pathway and Akt inactivation","volume":"7","author":"Zhang","year":"2012","journal-title":"PloS One"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404813","article-title":"Autocrine insulin-like growth factor-I signaling promotes growth and survival of human acute myeloid leukemia cells via the phosphoinositide 3-kinase\/Akt pathway","volume":"21","author":"Doepfner","year":"2007","journal-title":"Leukemia"},{"key":"B190","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3727\/096504010X12828372551821","article-title":"The insulin-like growth factor-1 receptor kinase inhibitor, NVP-ADW742, suppresses survival and resistance to chemotherapy in acute myeloid leukemia cells","volume":"19","author":"He","year":"2010","journal-title":"Oncol Res"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1620\/tjem.209.217","article-title":"Increased expression of insulin-like growth factor i is associated with Ara-C resistance in leukemia","volume":"209","author":"Abe","year":"2006","journal-title":"Tohoku J Exp Med"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S216628","article-title":"Suppressing Hedgehog signaling reverses drug resistance of refractory acute myeloid leukemia","volume":"12","author":"Huang","year":"2019","journal-title":"Onco Targets Ther"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-10-0318","article-title":"Compensatory insulin receptor (IR) activation on inhibition of insulin-like growth factor-1 receptor (IGF-1R): rationale for cotargeting IGF-1R and IR in cancer","volume":"9","author":"Buck","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2009.172","article-title":"Emerging role of insulin-like growth factor receptor inhibitors in oncology: early clinical trial results and future directions","volume":"28","author":"Gualberto","year":"2009","journal-title":"Oncogene"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404217","article-title":"Synergy between an IGF-1R antibody and Raf\/MEK\/ERK and PI3K\/Akt\/mTOR pathway inhibitors in suppressing IGF-1R-mediated growth in hematopoietic cells","volume":"20","author":"Bertrand","year":"2006","journal-title":"Leukemia"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.45765","article-title":"FLT3 mutations in acute myeloid leukemia: unraveling the molecular mechanisms and implications for targeted therapies","volume":"15","author":"Jalte","year":"2023","journal-title":"Cureus"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.01911","article-title":"Azacitidine, venetoclax, and gilteritinib in newly diagnosed and relapsed or refractory FLT3-mutated AML","volume":"42","author":"Short","year":"2024","journal-title":"J Clin Oncol"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-3522986\/v1","article-title":"Identification of ANGPT2, FLT3, IGF1 and SPP1 related to glycolysis and PI3K\/Akt signaling pathway in hepatocellular carcinoma","author":"Zhang","year":"2023"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-017-3161-0","article-title":"The role of mutant IDH1 and IDH2 inhibitors in the treatment of acute myeloid leukemia","volume":"96","author":"Nassereddine","year":"2017","journal-title":"Ann Hematol"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-04-779405","article-title":"Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia","volume":"130","author":"Stein","year":"2017","journal-title":"Blood"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.3171\/2018.8.JNS181217","article-title":"Suppression of tumor growth via IGFBP3 depletion as a potential treatment in glioma","volume":"132","author":"Chen","year":"2020","journal-title":"J Neurosurg"},{"key":"B202","doi-asserted-by":"publisher","first-page":"147638","DOI":"10.1016\/j.gene.2023.147638","article-title":"Radio-immunotherapy by (188)Re-antiCD20 and stable silencing of IGF-IR in Raji cells, new insight in treatment of lymphoma","volume":"882","author":"Nasehi","year":"2023","journal-title":"Gene"},{"key":"B203","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ctro.2017.09.006","article-title":"The impact of the IGF-1 system of cancer cells on radiation response - An in vitro study","volume":"7","author":"Venkatachalam","year":"2017","journal-title":"Clin Transl Radiat Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1540426\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T05:22:32Z","timestamp":1750742552000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1540426\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,24]]},"references-count":203,"alternative-id":["10.3389\/fonc.2025.1540426"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1540426","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,24]]},"article-number":"1540426"}}